13F-HR filed by Cormorant Asset Management, LP
Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-14, with 84 holding rows worth $906,836,000.
- Accession
- 0001583977-16-000008
- Filer
- CIK 1583977
- Filed
- 2016-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2016
A holdings report, 84 entries on the cover page, a total value of $906,836,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $906,836,000 with VALUE read as thousands by filing date, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerChen Bihua028-15950
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 1,689,071 | $55,351,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 491,044 | $51,260,000 | thousands by filing date | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 1,118,372 | $40,530,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 2,800,000 | $39,522,000 | thousands by filing date | |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 2,350,000 | $36,636,000 | thousands by filing date | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 1,988,208 | $34,496,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 455,995 | $31,920,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 1,771,263 | $30,519,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 2,071,964 | $26,811,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 1,605,790 | $26,239,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 650,000 | $23,433,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 901,286 | $23,082,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 2,787,717 | $21,800,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 334,044 | $21,441,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 707,978 | $21,176,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 398,301 | $20,170,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 1,695,000 | $18,916,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 800,000 | $16,904,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 507,907 | $16,492,000 | thousands by filing date | |
| SORRENTO THERAPEUTICS INC | 83587F202 | COMMON STOCK | 2,121,013 | $16,417,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 576,106 | $15,428,000 | thousands by filing date | |
| CHINA BIOLOGIC PRODUCTS INC | 16938C106 | COMM STK | 112,867 | $14,050,000 | thousands by filing date | |
| CORBUS PHARMACEUTICALS HLDGS | 21833P103 | COM | 2,000,000 | $13,580,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 596,000 | $13,535,000 | thousands by filing date | |
| CELLECTIS ADS | 15117K103 | COM | 498,117 | $11,995,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 1,578,106 | $11,331,000 | thousands by filing date | |
| INVUITY INC | 46187J205 | COM NEW | 767,466 | $10,530,000 | thousands by filing date | |
| ADVAXIS INC | 007624208 | COM NEW | 920,915 | $9,845,000 | thousands by filing date | |
| GEMPHIRE THERAPEUTICS INC | 36870A108 | COM | 900,000 | $9,828,000 | thousands by filing date | |
| CONTRAFECT CORP | 212326102 | COM | 3,840,966 | $9,526,000 | thousands by filing date | |
| INC RESH HLDGS INC | 45329R109 | CL A | 200,000 | $8,916,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 298,870 | $8,876,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 455,515 | $8,773,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 100,000 | $8,766,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 126,120 | $8,548,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 1,006,128 | $8,150,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 449,660 | $8,008,000 | thousands by filing date | |
| EMERGENT BIOSOLUTIONS INC | 29089Q105 | COM | 250,000 | $7,883,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 110,842 | $7,863,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 1,150,000 | $7,763,000 | thousands by filing date | |
| FULGENT GENETICS INC | 359664109 | COM | 800,000 | $7,376,000 | thousands by filing date | |
| FORWARD PHARMA A/S | 34986J105 | SPONSORED ADR | 339,175 | $7,123,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 1,402,331 | $6,493,000 | thousands by filing date | |
| CURIS INC | 231269101 | COM | 2,410,900 | $6,292,000 | thousands by filing date | |
| ZYNERBA PHARMACEUTICALS INC | 98986X109 | COM | 480,501 | $6,271,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 669,239 | $5,916,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 371,636 | $5,827,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 172,083 | $5,820,000 | thousands by filing date | |
| PFENEX INC | 717071104 | COM | 632,559 | $5,661,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 131,858 | $5,434,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P107 | COM | 800,000 | $4,928,000 | thousands by filing date | |
| INTEC PHARMA LTD JERUSALEM | M53644106 | SHS | 809,804 | $4,762,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 127,451 | $4,612,000 | thousands by filing date | |
| ONCOBIOLOGICS INC | 68235M105 | COM | 1,027,216 | $4,366,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,155,600 | $4,241,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 505,941 | $4,164,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 186,460 | $3,988,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 563,880 | $3,936,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 240,403 | $3,645,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 214,132 | $3,522,000 | thousands by filing date | |
| LIPOCINE INC NEW | 53630X104 | CMN | 751,296 | $3,351,000 | thousands by filing date | |
| IMMUNE DESIGN CORP. | 45252L103 | Common Stock | 432,990 | $3,282,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 990,579 | $2,229,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 156,741 | $2,196,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 287,031 | $2,052,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 151,838 | $2,029,000 | thousands by filing date | |
| CELYAD ONCOLOGY SA | 151205200 | ADR | 75,920 | $1,791,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 159,513 | $1,570,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 62,254 | $1,251,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 151,838 | $1,124,000 | thousands by filing date | |
| AVEO PHARMACEUTICALS INC | 053588109 | COM | 1,087,715 | $968,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 40,490 | $809,000 | thousands by filing date | |
| THRESHOLD PHARMACEUTICAL INC | 885807206 | COM NEW | 1,012,255 | $686,000 | thousands by filing date | |
| ONCOBIOLOGICS INC | 68235M121 | *W EXP 05/18/201 | 416,666 | $500,000 | thousands by filing date | |
| HTG MOLECULAR DIAGNOSTICS IN | 40434H104 | COM | 203,464 | $472,000 | thousands by filing date | |
| GENVEC INC NEW | 37246C307 | cs | 1,015,685 | $468,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 50,613 | $333,000 | thousands by filing date | |
| PROVECTUS BIOPHARMACEUTICALS | 74373P108 | COMMON STOCK | 2,226,961 | $221,000 | thousands by filing date | |
| ONCOBIOLOG-CW17A | 68235M113 | EQUITY WRT | 416,666 | $199,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 25,307 | $178,000 | thousands by filing date | |
| APPLIED GENETIC TECHNOL CORP | 03820J100 | COM | 17,321 | $169,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F302 | COM | 53,649 | $145,000 | thousands by filing date | |
| PROVECTUS BIOPHARMACEUTICALS | 74373P116 | *W EXP 06/19/202 | 2,200,000 | $114,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F120 | *W EXP 08/20/201 | 52,999 | $13,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001583977-16-000008 | this filing | 2016-11-14 | acceptance time not in the bulk data set |